Selecta Biosciences (SELB) Tops Q1 EPS by 34c

Selecta Biosciences (NASDAQ: SELB) reported Q1 EPS of $0.23, $0.34 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $34 million versus the consensus estimate of $13.12 million.

For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
• SonicStrategy signs LOI to acquire AI assets from ARKLAB AI